CONR Conor Medsystems

MENLO PARK, California, Feb. 23 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) is scheduled to present at the Citigroup Healthcare Conference on Tuesday, February 28, 2006. Frank Litvack, M.D., Chairman and CEO, will provide a corporate update at 2:30 PM Eastern Time, at the Mayflower Hotel in Washington, D.C. To access the live audio broadcast or the subsequent archived recording, visit the events calendar section of the company's website located at http://www.conormed.com/. The recording will be archived for 30 days following the live presentation. Please log on to Conor's website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary. About Conor Medsystems Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug-eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit http://www.conormed.com/. DATASOURCE: Conor Medsystems, Inc. CONTACT: investors, Michael Boennighausen, Chief Financial Officer of Conor Medsystems, Inc., +1-650-614-4100; or media, Karen L. Bergman of BCC Partners, +1-650-575-1509, for Conor Medsystems, Inc. Web site: http://www.conormed.com/

Copyright